Sunday - February 22, 2026

Crystalline Salts of a Plasma Kallikrein Inhibitor

2026-02-17

ALEXANDRIA, Virginia, Feb. 17 -- BIOCRYST PHARMACEUTICALS, INC., Durham, North Carolina has been assigned a patent (No. US 12552750 B2, initially filed Aug. 28, 2025) developed by Yahya El-Kattan, Vestavia Hills, Alabama, and Yarlagadda S. Babu, Birmingham, Alabama, for "Crystalline salts of a plasma kallikrein inhibitor." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Crystalline Salts of a Plasma Kallikrein Inhibitor

Information Request Form

Copyright Targeted News Service 2026